Acta Med Acad

1. SHABANI V, Reci M, Veselievska Stojkovska V
   Cervical Cytology and Age in HPV-Infected Women in North Macedonia: A Cross-Sectional Study.
   Acta Med Acad. 2026;55:21-29.
   

   >> Share

   
   

   
   Adv Anat Pathol

2. SATTURWAR S, Parwani AV, Li Z
   Advances in Digital Cytopathology and Artificial Intelligence Applications.
   Adv Anat Pathol. 2026;33:190-200.
   

   >> Share

   
   

   
   Biochem Biophys Res Commun

3. QIAN D, Zhao L, Lin F, Wang L, et al
   Oncolytic human adenovirus 5 (H101) modulates cell cycle progression in HPV16-positive tumors.
   Biochem Biophys Res Commun. 2026;818:153747.
   

   >> Share

   
   

   
   BMC Health Serv Res

4. LIN B, Gruschow K, Burke A, Zhou X, et al
   Supporting breast and cervical cancer screening follow-up: qualitative health plan interviews.
   BMC Health Serv Res. 2026 May 2. doi: 10.1186/s12913-026-14641.
   

   >> Share

   
   

   
   BMC Prim Care

5. PRABHAKARAN A, Mathias EG, Sathiyamoorthy R, Bebarta NK, et al
   Caring for the caregivers: breast and cervical cancer screening among informal caregivers of cancer patients - a scoping review.
   BMC Prim Care. 2026 May 4. doi: 10.1186/s12875-026-03333.
   

   >> Share

   
   

   
   BMJ Glob Health

6. KEBEDE HK, Gesesew HA, Mwanri L, Ward P, et al
   HIV care continuity for women in postconflict Tigray: assessing mother-to-child transmission rates, infant health and cervical cancer screening.
   BMJ Glob Health. 2026;11:e023272.
   

   >> Share

   
   

   
   Cancer

7. LAWRENCE L
   HRSA recommends offering self-collection for cervical cancer screening.
   Cancer. 2026;132:e70369.
   

   >> Share

   
   

   
   Cancer Biother Radiopharm

8. MA Z, Cai Y, Zhang L, Tian C, et al
   LINC00319 Promotes Cervical Cancer Progression Via Targeting miR-147a/IGF1R Pathway.
   Cancer Biother Radiopharm. 2026;41:234-243.
   

   >> Share

   
   
9. LIN L, Li N, Hu X, Sun J, et al
   Identification of circ_0085616 as an Upregulated and Oncogenic Circular RNA in Cervical Cancer Via the miR-503-5p-Mediated ATXN7L3 Activation.
   Cancer Biother Radiopharm. 2026;41:244-256.
   

   >> Share

   
   

   
   Cancer Control

10. PAOLINO M, Basu P, Lucas E, Cucchiaro M, et al
    Barriers and Facilitators of Programmatic HPV Testing: Lessons Learnt From Two In-Depth Provincial Case Studies Ten Years After the Jujuy Demonstration Project in Argentina.
    Cancer Control. 2026;33:10732748261446046.
    

    >> Share

    
    
11. MCNICHOLAS C, Memmel L, Kaplan C, Hwang Y, et al
    Addressing Cervical Cancer Screening Disparities: At-Home Self-Collection Among LGBQ+ Populations.
    Cancer Control. 2026;33:10732748261448263.
    

    >> Share

    
    

    
    Cancer Cytopathol

12. RAMSEYER TG, Batson B, Wu D, Matsko JL, et al
    Pap testing and high-risk HPV testing for women aged 65 years and older with surgical pathology follow-up.
    Cancer Cytopathol. 2026;134:e70111.
    

    >> Share

    
    

    
    Cancer Epidemiol

13. DEBANTH A, Achary T, Halder P, Dasgupta A, et al
    Time to treatment initiation delays in cervical cancer worldwide: A systematic review and meta-analysis.
    Cancer Epidemiol. 2026;103:103095.
    

    >> Share

    
    

    
    Cancers (Basel)

14. THAIJIAM C, Navaitthiporn N, Rithcharung P, Piyawattanametha N, et al
    Development of a Telehealth-Enabled Portable Optical Endomicroscopy System with Targeted Peptides: A Preclinical Feasibility Study for Cervical Cancer Detection.
    Cancers (Basel). 2026;18:1306.
    

    >> Share

    
    

    
    Cell Death Dis

15. SHI Y, Zhang Z, Liu J, Zhu C, et al
    RILPL2 suppresses metabolic reprogramming and progression of cervical cancer by attenuating LDHA protein stability and inhibiting H3K18 lactylation.
    Cell Death Dis. 2026 May 4. doi: 10.1038/s41419-026-08808.
    

    >> Share

    
    

    
    Clin Adv Hematol Oncol

16. DUSKA LR
    Update on immune checkpoint inhibition for cervical cancer.
    Clin Adv Hematol Oncol. 2026;24:167-169.
    

    >> Share

    
    

    
    Clin Nucl Med

17. LIANG C, Li M, Wang H, He T, et al
    Lower Limb Nonvisualization Caused by Macroarterial Thrombosis After Cervical Cancer TP Chemotherapy in Whole-body Bone Scintigraphy.
    Clin Nucl Med. 2026;51:497-499.
    

    >> Share

    
    

    
    Curr Cancer Drug Targets

18. B VS, Prabhu A, Koumar RC
    Splicing: A New Dimension in Decoding the Complex Traits for Cervical Cancer.
    Curr Cancer Drug Targets. 2026 Apr 27. doi: 10.2174/0115680096409242251125093718
    

    >> Share

    
    

    
    Curr Gene Ther

19. ZHANG H, Li J, Xu H, Zhang S, et al
    Identifying Key Epigenetic Modification-Related Genes for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma and Cellular Validation.
    Curr Gene Ther. 2026;26:1-13.
    

    >> Share

    
    

    
    Diagnostics (Basel)

20. LUCA DC, Cirimbei C, Ionescu SO, Rotaru V, et al
    Global and Regional Diagnostic Results of Progress Toward Cervical Cancer Elimination, According to the WHO Strategy: A Systematic Review.
    Diagnostics (Basel). 2026;16:1224.
    

    >> Share

    
    

    
    Drug Dev Ind Pharm

21. RAIMUNDO GA, Batistella T, Johann Fensterseifer M, Silveira da Silva L, et al
    Injection molded multidrug intravaginal rings with antimicrobial properties for prophylaxis and cancer treatment in women's health context.
    Drug Dev Ind Pharm. 2026;52:853-865.
    

    >> Share

    
    

    
    FASEB J

22. CHI C, Xu M, Zhang J, Zhang Y, et al
    CAF-Secreted Exosomes Deliver BMP4 to Confer Radiotherapy Resistance in Cervical Cancer Through a Novel Mechanism Linking Nrf2 Activation to Cuproptosis Inhibition.
    FASEB J. 2026;40:e71838.
    

    >> Share

    
    
23. ZHOU Y, Liu H, Pan S, Ruan L, et al
    Simvastatin Restores Cisplatin Sensitivity by Suppressing the Caveolin-1-Mediated PI3K/AKT Signaling Pathway in Cisplatin-Resistant Cervical Cancer Cells.
    FASEB J. 2026;40:e71873.
    

    >> Share

    
    

    
    Front Immunol

24. WANG X, Zhang Y, Wang C, Huang L, et al
    Efficacy and safety of first-line therapies for persistent, recurrent, or metastatic cervical cancer: a systematic review and exploratory network meta-analysis of immunotherapy.
    Front Immunol. 2026;17:1789532.
    

    >> Share

    
    

    
    Front Microbiol

25. JI X, Ji X, Chen S, Wang X, et al
    Diagnostic accuracy of self-collected menstrual blood for high-risk human papillomavirus testing for cervical intraepithelial neoplasia and cervical cancer: a systematic review and meta-analysis.
    Front Microbiol. 2026;17:1782917.
    

    >> Share

    
    

    
    Front Oncol

26. AKINTOLA A, Dareng EO, Adebamowo SN, Adebamowo CA, et al
    Impact of educational intervention on the uptake of self-sampling for HPV test-based cervical cancer screening.
    Front Oncol. 2026;16:1810950.
    

    >> Share

    
    
27. YANG J, Song L, Yin R, Zhong L, et al
    Cervical cancer with BRCA1 gene mutations: case reports and literature review.
    Front Oncol. 2026;16:1742990.
    

    >> Share

    
    

    
    Front Pharmacol

28. LAN J, Lu J, Dina T, Li Y, et al
    Akiferidin suppresses cervical cancer growth and angiogenesis via the VEGF/DLL4-Notch pathway.
    Front Pharmacol. 2026;17:1803135.
    

    >> Share

    
    

    
    Front Public Health

29. GORAL S, Liljander A, Kai M, Cavalar M, et al
    High-risk and low-risk human papillomavirus detection in self-collected samples compared to clinician-collected samples in a Polish population.
    Front Public Health. 2026;14:1804719.
    

    >> Share

    
    
30. MOHAMED YB, Karimi SM
    A comprehensive review of HPV vaccination policies in the United States.
    Front Public Health. 2026;14:1810845.
    

    >> Share

    
    

    
    Gynecol Oncol Rep

31. CORN E, Becht K, Adefres B, Monare B, et al
    The challenges of implementing less invasive surgical management for cervical cancer in a limited-resource setting in Botswana: A case series.
    Gynecol Oncol Rep. 2026;65:102089.
    

    >> Share

    
    

    
    Hum Vaccin Immunother

32. YAN Y, Guan S, Chen W, Shi J, et al
    Trends, disparities, and multilevel interventions: A global review of HPV vaccination among university students.
    Hum Vaccin Immunother. 2026;22:2667395.
    

    >> Share

    
    

    
    Immun Inflamm Dis

33. VAHEDPOOR Z, Matini A, Rahimi H, Lotfinia M, et al
    Expression of Programmed Death-Ligand 1 in Cervical Cancer: Correlation With Histologic Subtypes and Clinicopathological Features.
    Immun Inflamm Dis. 2026;14:e70464.
    

    >> Share

    
    

    
    Indian J Public Health

34. SHARMA J, Yennapu M, Kumar V
    Implementation Barriers to Cervical Cancer Screening Program in Primary Health Facilities of South Delhi: A Qualitative Inquiry.
    Indian J Public Health. 2026 Apr 18. doi: 10.4103.
    

    >> Share

    
    

    
    Int J Environ Res Public Health

35. BOLARINWA O, Bashir SG, Okyere J, Abdi YH, et al
    Burden, Regional Trends and Risk Factors of Breast, Cervical, Uterine, and Ovarian Cancers in Sub-Saharan Africa, 1990-2023: The Global Burden of Disease 2023.
    Int J Environ Res Public Health. 2026;23:419.
    

    >> Share

    
    

    
    Int J Gynecol Cancer

36. WANG XS, Pond GR, Piedimonte S, Nelson G, et al
    Pre-operative positron emission tomography scan is associated with lower rates of adjuvant treatment in surgically treated patients with cervical cancer: a 4C Working Group study.
    Int J Gynecol Cancer. 2026;36:104695.
    

    >> Share

    
    
37. LIM H, Lee C, Back JW, Seol A, et al
    Association of primary treatment modality and programmed death-ligand 1 expression with survival outcomes in locally advanced human papillomavirus-independent endocervical adenocarcinoma.
    Int J Gynecol Cancer. 2026;36:104652.
    

    >> Share

    
    
38. KOBAYASHI M, Nakagawa S, Matsuzaki S, Ouzounian AJ, et al
    Treatment modality-specific survival of small cell neuroendocrine carcinoma of the uterine cervix with T1b3-2b classifications.
    Int J Gynecol Cancer. 2026;36:104644.
    

    >> Share

    
    

    
    Int J Technol Assess Health Care

39. GHASRI S, Johnson EE, Harris BM, Forsythe I, et al
    Barriers and facilitators to using self-sampled tests for the human papillomavirus (HPV): a mixed-methods study to inform a horizon scan.
    Int J Technol Assess Health Care. 2026;42:e46.
    

    >> Share

    
    

    
    Int J Telemed Appl

40. ALANAZI AM, Dardouri S
    CERV-Score: A Hybrid Machine Learning Framework for Cervical Cancer Risk Prediction Using Integrated Clinical and Genomic Data.
    Int J Telemed Appl. 2026;2026:9913421.
    

    >> Share

    
    

    
    J Appl Clin Med Phys

41. THAYER-FREEMAN C, Washington B, Cheek D, Luo W, et al
    Impact of variation in the alpha/beta of cervical cancer on predicted clinical outcomes.
    J Appl Clin Med Phys. 2026;27:e70608.
    

    >> Share

    
    

    
    J Cancer Policy

42. THI NGOC TOAN A, Palmer MR, Phung TL, Nguyen PT, et al
    Trends and disparities in cervical cancer screening prevalence in Vietnam: Evidence from the 2015 and 2021 WHO STEPS surveys.
    J Cancer Policy. 2026;48:100748.
    

    >> Share

    
    

    
    J Chem Inf Model

43. TODSAPORN D, Sanachai K, Suddee N, Kanjanapanyakom C, et al
    Integrating QSAR-Machine Learning, Biochemical Assays, and Molecular Dynamics for the Discovery of JAK2 Inhibitors in Cervical Cancer.
    J Chem Inf Model. 2026 May 5. doi: 10.1021/acs.jcim.6c00414.
    

    >> Share

    
    

    
    J Multidiscip Healthc

44. LUMIA C, Fumagalli S, Martinelli M, Ausili D, et al
    Adherence to HPV-Based Cervical Cancer Screening: A Concept Analysis for Nursing and Midwifery Practice.
    J Multidiscip Healthc. 2026;19:601358.
    

    >> Share

    
    

    
    J Obstet Gynaecol Can

45. LEWIS JA, Foote S, Cooper E, Butterley C, et al
    Enhancing Human Papillomavirus Vaccination Uptake After Loop Electrosurgical Excision Procedure (LEEP) at Colposcopy: A Quality Improvement Study.
    J Obstet Gynaecol Can. 2026;48:103266.
    

    >> Share

    
    
46. BENOIT M, Makki H, Almadin C, Lacaille J, et al
    Colposcopy Follow-up and Findings in Women with Lower-Grade Lesions on Screening Cytology Who were Eligible for Free Human Papillomavirus Vaccination.
    J Obstet Gynaecol Can. 2026;48:103267.
    

    >> Share

    
    

    
    J Obstet Gynaecol Res

47. USSO AA, Mohammed H, Ahmed M
    Cervical Cancer Screening Utilization Among Female Health Workers in Ethiopia: A Systematic Review and Meta-Analysis.
    J Obstet Gynaecol Res. 2026;52:e70313.
    

    >> Share

    
    

    
    J Oncol Pharm Pract

48. CV S, Prakash GH, B Darukaradhya T
    Cervical cancer and human papillomavirus (HPV) vaccination awareness Among university students: A global scoping review of knowledge, attitudes, and barriers.
    J Oncol Pharm Pract. 2026 May 7:10781552261446556.
    

    >> Share

    
    

    
    J Pharm Sci

49. ODEI-MENSAH B, Adeyemi SA, Ngema LM, Mndlovu H, et al
    Nano-enabled targeted transdermal therapy for pain management in cervical cancer.
    J Pharm Sci. 2026 May 4:104313. doi: 10.1016/j.xphs.2026.104313.
    

    >> Share

    
    

    
    J Transl Med

50. DENG X, Zhu T, Wang Y, Hu B, et al
    Reinforcement learning-based WSI diagnostic system for cervical squamous cell carcinoma and precancerous lesions.
    J Transl Med. 2026;24:632.
    

    >> Share

    
    

    
    J Ultrasound Med

51. CHEN J, Guo Y, Tang Y, Xiao R, et al
    Clinical and Imaging Features of Gastric-Type Endocervical Adenocarcinoma: A Report of 9 Cases with Literature Review.
    J Ultrasound Med. 2026;45:1289-1296.
    

    >> Share

    
    

    
    Lancet

52. BRISSON M, Drolet M, Gingras G, Laprise JF, et al
    Substantial increases in cervical cancer inequalities worldwide without enhanced human papillomavirus vaccination and screening efforts: a global modelling study.
    Lancet. 2026;407:1726-1737.
    

    >> Share

    
    
53. CLIFFORD GM
    HPV vaccine scale-up is key to curb rising cervical cancer inequalities.
    Lancet. 2026;407:1662-1663.
    

    >> Share

    
    

    
    Lancet Reg Health Am

54. HARPER DM, Young AP
    Cervical cancer screening intervals extendable to ten years for 9v HPV vaccinated persons.
    Lancet Reg Health Am. 2026;58:101486.
    

    >> Share

    
    

    
    Malays J Med Sci

55. ISMAIL F, Zakaria Y, Md Isa ML, Nik Hassan NF, et al
    SF1, a Standardised Fraction from Clinacanthus nutans Modulates Notch1 Signalling in Cervical Cancer Stem-Like Cells.
    Malays J Med Sci. 2025;32:38-50.
    

    >> Share

    
    

    
    Medicina (Kaunas)

56. SOZEN I, Sahin G, Ulu Y, Yitiz D, et al
    Cytology-Biopsy Concordance in High-Risk Human Papillomavirus-Positive Women with Abnormal Cytology Findings: Menopause-Stratified Analysis.
    Medicina (Kaunas). 2026;62:631.
    

    >> Share

    
    

    
    Patient Educ Couns

57. CHEPKORIR J, Kim T, Zamora M, Han HR, et al
    Patient portal notifications for breast and cervical cancer screening results: Perspectives of women with limited english proficiency.
    Patient Educ Couns. 2026;149:109651.
    

    >> Share

    
    

    
    Pharmaceutics

58. BAI J, Huang J, Zhang Q, Su W, et al
    Preparation of PSA-DOX/ICG-Lip and Evaluation of Its Efficacy Against Cervical Cancer.
    Pharmaceutics. 2026;18:434.
    

    >> Share

    
    

    
    PLOS Glob Public Health

59. MARTINEZ MONTANEZ OG, Pico-Guzman FJ, Zavaleta GG, Tinoco Vazquez HR, et al
    The cost-saving impact of human papillomavirus self-sampling for cervical cancer screening in women workers at the manufacturing sector in Ciudad Juarez, Chihuahua, Mexico.
    PLOS Glob Public Health. 2026;6:e0006389.
    

    >> Share

    
    

    
    PLoS One

60. ESSAYAGH T, Essayagh M, Nmila K, Slibani H, et al
    Prevalence and determinants of parental refusal of human papillomavirus vaccination in Morocco: A multicenter cross-sectional study.
    PLoS One. 2026;21:e0348586.
    

    >> Share

    
    

    
    Radiat Res

61. WANG JN, Liao LL, Yang F, Wang R, et al
    TSPAN8-mediated Epithelial-mesenchymal Transition Drives Acquired Radioresistance in Cervical Cancer.
    Radiat Res. 2026;205:513-527.
    

    >> Share

    
    

    
    Reprod Health

62. WENANG S, Sugiyo D, Sutantri S, Febrianti L, et al
    Population-based self-sampling under primary care conditions - a possible approach for cervical cancer screening in Indonesia (IndoCerCa study).
    Reprod Health. 2026 May 8. doi: 10.1186/s12978-026-02350.
    

    >> Share

    
    

    
    Rev Med Inst Mex Seguro Soc

63. PEREZ-SANTOME I, Morales-Bravo SJ, Dominguez-Canto T
    [Risk factors for cervical intraepithelial lesions among beneficiaries of second-level care].
    Rev Med Inst Mex Seguro Soc. 2026;64:e6792.
    

    >> Share

    
    

    
    Sci Rep

64. CHAUHAN NK, Kumar A, Jain A, Singh K, et al
    Optimizing cervical cancer diagnosis with a hybrid deep neural network and progressive resizing on pap smear WSIs.
    Sci Rep. 2026 May 6. doi: 10.1038/s41598-026-49654.
    

    >> Share

    
    

    
    Transl Res

65. ZHOU W, Xu Q, Qiu T, Wang J, et al
    Importin-7 Facilitates Cervical Cancer Progression Through MSI2 Nuclear Import and Is Associated With MSI2-MYC-Linked Glycolytic Reprogramming.
    Transl Res. 2026 Apr 29:S1931-5244(26)00087-3. doi: 10.1016/j.trsl.2026.
    

    >> Share

    
    

    
    Vaccine

66. XU MA, Pant S, DiClemente RJ
    Factors affecting human papillomavirus vaccination: A review of individual, interpersonal, and structural factors affecting vaccine uptake among adolescents.
    Vaccine. 2026;81:128563.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share